KONTAFARMA CHINA HOLDINGS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.028 HKD | -22.22% |
|
-17.65% | -22.22% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Kontafarma China Holdings Ltd, formely Tongfang Kontafarma Holdings Ltd, is an investment holding company principally engaged in pharmaceutical business. The Company operates its business through two business segments. The Pharmaceutical Business segment is engaged in the manufacture and sale of prescription drugs, including chemical drugs and prescribed traditional Chinese medicines, and laboratory related products. The Fitness Business is segment is engaged in the operation of fitness centers, the provision of consultation services for fitness and health activities, as well as the operation of the franchise business for royalty fee income.
Sector
Pharmaceuticals
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -22.22% | 19.98M | |
| +25.61% | 660B | |
| +25.87% | 562B | |
| -5.24% | 358B | |
| +16.49% | 322B | |
| +8.28% | 297B | |
| +7.09% | 219B | |
| -9.12% | 196B | |
| +5.01% | 199B | |
| -8.75% | 149B |
- Stock Market
- Equities
- 1312 Stock
- News Kontafarma China Holdings Limited
- Tongfang Kontafarma Arm Selling Full Stake in US Drug Discovery Firm for $16 Million
